Thank you. Good afternoon and thanks for joining our conference call to discuss our fourth quarter and full year 2022 financial results. I’d like to remind everyone that this call is available for replay via telephonic dial-in through March 29 and by way of live webcast that will be posted in the Investor Relations portion of our website at ir.naturessunshine.com. The information on this call contains forward-looking statements. These statements are often characterized by terminologies such as believe, hope, may, anticipate, expect, will and other similar expressions. Forward-looking statements are not guarantees of future performance and the actual results may be materially different from the results implied by forward-looking statements. Factors that could cause results to differ materially from those implied herein, include, but are not limited to, those factors disclosed in the company’s annual report on Form 10-K under the caption Risk Factors and other reports filed with the Securities and Exchange Commission. The information on this call speaks only as of today’s date and the company disclaims any duty to update the information provided herein. Now I'd like to turn the call over to the CEO of Nature’s Sunshine, Terrence Moorehead. Terrence?

Thank you, Nate, and good afternoon, everyone. I want to thank you for joining today’s call to discuss our fourth quarter and full year results. On the call with me is our new Chief Financial Officer, Shane Jones, and I'd like to take a moment to officially welcome Shane to Nature's Sunshine and say what a pleasure it is to have him as part of our management team. Shane joined the company in December and brings over 25 years of experience, having previously served as the Chief Financial Officer at well-known companies such as West Marine, 1-800 CONTACTS and Backcountry.com. In his role as CFO, Shane will be working closely with our management team to improve performance and drive sustainable, profitable growth across the business. He's already added significant value, as we continue to take steps to mitigate external cost pressures, drive efficiency and build financial resilience into the business. Today, I'll provide some context to our fourth quarter and full year 2022 results and give some details on how we believe the business continues to develop. Shane will then take you through the specifics of our financials in more detail. Turning to the fourth quarter, we continue to recalibrate and adjust to the changing macroeconomic environment and shifts in consumer behavior, but saw several encouraging signs in the quarter. First, Asia-Pacific continued to deliver strong results as we've done a good job diversifying our portfolio in the region. We've contemporized the business and built strong field fundamentals that continue to create new opportunities for incremental growth. Second, our business in Central and Eastern Europe continued to show signs of stabilizing, as we rewired operating practices to address the new reality on the ground and expanded our footprint to include a few new markets that helped partially offset the unique risks of doing business in that part of the world. Third, our digital initiatives continued to demonstrate strong potential to drive new customer acquisition and the integration of our Amazon business into our internal processes is expected to enhance our focus and improve performance moving forward. And finally, the product stock-out issues that slowed our business in the first half of 2022 appeared to be returning to pre-COVID levels as we saw product availability improve across the board. At the same time, macroeconomic and geopolitical headwinds continued to negatively impact both our top and bottom line business dynamics in the fourth quarter. Despite the external headwinds, we were still able to move our key initiatives forward and deliver resilient results. Consolidated fourth quarter net sales on a reported basis came in at $103 million or $110 million when removing the impact of foreign exchange, which is a 6% decrease versus the prior year. You'll remember last year's fourth quarter was the largest quarter in the company's history with each of our operating business units delivering strong growth. Clearly, we're operating in an extremely challenging external environment, but we believe the underlying fundamentals and strength of our brand remain firmly intact and that the steps we've taken to create a more diverse, consumer-focused portfolio will build momentum as the external headwinds subside. Looking at the full year, we reported net sales of $422 million, making 2022 our second-best year in the company's history. When you adjust for the impact of foreign exchange, our 2022 sales were $445 million, which is up slightly versus the prior year, again, a tremendous accomplishment given the unprecedented headwinds we faced. To be specific, foreign exchange wiped away about $23 million in sales for the year. A closer look shows that Asia Pacific drove our performance in the fourth quarter as well as the full year led by Japan and Taiwan. On a constant currency basis, Asia was up 5% in the fourth quarter and 16% for the full year. The growth was fueled by our investment in field activation that helped drive order growth and counteract the residual effects of China's zero COVID policy. It's worth noting that while China was a drag on the quarter, sales momentum increased each month as the country started to reopen. We're hopeful this trend continues, but the situation is fluid. Looking forward to 2023, we believe a continued focus on targeted new product introductions, next-generation branding, and sustained investment in field activation will allow us to continue to drive profitable growth in Asia in 2023. Our business in Europe continued to be resilient with sales for the quarter and full year performing better than expected, due to the incredible resolve of our team in Central and Eastern Europe. For the fourth quarter, sales were down 17% and were down 10% for the full year in constant currency versus last year's historic results. Macroeconomic and geopolitical challenges saw consumer spending decline sharply, negatively impacting orders and average order. Fortunately, our investment in customer growth helps support geographic penetration in new markets like Turkey and the Baltic states, partially filling the gap from lost sales in Ukraine. As we move into 2023, we believe continued stability in Central and Eastern Europe combined with strong execution of our field fundamentals will create opportunities for us to deliver modest growth in the region. In North America, orders remained relatively flat versus the prior year, but the business continued to be challenged by average order declines from customers who bought about one less unit on average per order. This is consistent with the broader market where we saw consumers offsetting inflationary pressures by purchasing smaller quantities, delaying purchases, or trading down to cheaper brands. As a result, fourth quarter sales were down 14% while full year sales were down 11%. Our investment in digital activation continued to gain traction, driving new customer acquisition and adding new members to our Subscribe and Thrive auto ship program, which now represents about 26% of sales and continued to increase versus the prior year. We continue to see encouraging signs from our digital business. As we move forward, we believe there's an opportunity to stabilize the North American business in the latter half of 2023 by continuing to expand our digital footprint, bringing our Amazon business in-house, and by increasing the number of nutrition health practitioners recommending our products, thus extending our leadership position as the number one nutrition health practitioner brand. The fourth quarter also saw continued pressure on gross margins with a 180 basis point loss in gross margin from inflation and foreign exchange that negatively impacted cost of goods. Last quarter, I invited our new supply chain leader, Martin Gonzalez, to walk you through our plans to improve gross margin with a series of initiatives designed to streamline our operations and drive out costs. Since then, we've made significant progress on our $10 million to $12 million gross savings target. We've identified the specific savings initiatives and have moved into the execution phase of the plan. It's important to note however, that the benefit of these actions won't start being reflected in our results until the end of 2023, with the material impact coming in 2024. The structural changes we're making to our product line and supply chain operations will provide significant improvements to gross margin, but many of the initiatives involve redesigning processes and revamping sourcing relationships. Doing this requires time and resources to redesign workflows, reformulate products, test them, cycle through old inventory by selling off legacy products, and then selling the reformulated products into the market. Again, this is an end-to-end restructuring of our supply chain, so it requires time and resources to do it right. In the end, the results will be significant and meaningful. In the meantime, we're planning strategic price increases in Asia-Pacific, Europe, LatAm, and North America to help offset the impact of inflationary headwinds and improve profitability. In challenging times like these, we believe it's more important than ever to stay focused, keep moving forward, and lean into our strategies, and that's exactly what we're going to do. As we move into 2023, we're focused on restoring growth and building positive momentum, delivering low to mid-single digit revenue growth for the year. To achieve this, we've streamlined our global strategies to focus on three key priorities. Brand power strategies will focus on creating more powerful new products to fuel customer growth. Field energy will focus on attracting a new generation of digitally-enabled distributors, retailers, and nutrition health practitioners, and digital-first will focus on building customer acquisition and retention capabilities around the globe. In closing, I want to reiterate our steadfast commitment to successfully navigating this unique period of market uncertainty. And I want to leave you with a few takeaways. First, the underlying fundamentals of our business are solid, and our ability to drive customer activation remains well intact. Second, we have a strong balance sheet with the appropriate level of cash and liquidity to fund our strategies and key initiatives. And third, we're fighting back against the external macroeconomic environment with a roadmap that improves gross margins and overall profitability to make us more valuable and more competitive in the future. With that, I'd like to turn the call over to Shane.

Thank you, Terrence. It's great to be here today. Jumping right into our results, net sales in the fourth quarter were $102.7 million compared to $117.9 million in the year-ago quarter. This 13% decline was largely driven by reduced sales in China, Europe, and North America. As Terrence mentioned, excluding the impact from foreign exchange rates, consolidated net sales decreased 6% in the fourth quarter versus last year. Gross margin in the fourth quarter was 72.2% compared to 74.0% a year ago. The decline was primarily driven by foreign exchange headwinds, increases in material production, transportation, and distribution costs, as well as changes in market mix. These headwinds were partially offset by a one-time $0.7 million add-back related to the partial reversal of the reserves taken earlier in 2022 for the Russia and Ukraine conflict. Volume incentives in the fourth quarter declined 9% to $31.1 million compared to $34.4 million in the year-ago quarter. As a percentage of net sales, volume incentives were 30.3% compared to 29.1% in the year-ago quarter. The increase in volume incentives as a percentage of net sales is primarily due to changes in market mix. Selling, general and administrative expenses during the fourth quarter declined 15% to $38.8 million compared to $45.4 million in the year-ago quarter. This reduction was driven by lower service fees in China, variable costs related to lower sales and lower compensation costs. These reductions were slightly offset by a one-time impairment of fixed assets of $1.1 million. As a percentage of net sales, SG&A expenses were 37.8% for the fourth quarter of 2022 compared to 38.5% in the year-ago quarter. Reflective of the gross margin pressures, operating income was $4.2 million or 4.1% of net sales compared to $7.5 million or 6.4% of net sales. GAAP net income attributable to common shareholders for the fourth quarter was $2.0 million or $0.10 per diluted share as compared to $13.4 million or $0.67 per diluted share in the year-ago quarter. The change in GAAP net income reflects reduced operating income as well as an unfavorable change in our income tax provision related to a valuation allowance for foreign tax credits in our expected utilization of NOLs in some markets. Adjusted EBITDA, as defined in our earnings release, was $8.0 million compared to $11.6 million in the fourth quarter of 2021. Moving on to our liquidity and our capital allocation plan; our balance sheet remains clean with cash and cash equivalents of $60 million and only $1.2 million of debt. Inventory was flat in Q4 compared to where we ended Q3. In 2023, we expect to right-size the amount of inventory within our supply chain as we continue to meet strong demand in Asia, and as China continues its reopening curve. As a part of our capital allocation plan, we continue to utilize our share repurchase authorization buying 909,000 shares in a full year for $13.6 million, or an average of $14.93 per share. As of December 31, 2022, $24.0 million remains of our share repurchase program. Looking beyond share repurchases, our healthy capital allocation structure positions us well to continue our digital transformation and strategic investments. Before moving to our outlook for 2023, I would like to address the situation we made public on February 24. Our company was the victim of a sophisticated phishing attack that targeted Synergy Japan, which our team self-discovered on February 17. The incident involved employee impersonation and fraudulent financial requests, which resulted in fraudulently induced wire transfers during the month of February. As a result of this event, we expect to record a one-time pre-tax charge of up to $4.8 million in the first quarter of 2023. To date, we have found no evidence of additional fraudulent activity and are working with our banking partners as well as federal and local authorities to investigate this matter and recover as much of the funds as possible. Now turning to our 2023 outlook; so far during Q1, we have experienced sequential improvements across most of our markets, and we expect to report sales growth for the whole year in the low to mid-single digit range. Keep in mind that Q1 of 2023 will be compared to a relatively strong period last year when many of the headwinds we are facing weren't so pronounced. However, the comparisons will ease as we move through the year. We do expect inflation and foreign exchange headwinds to continue to have a negative impact on our cost of sales in the first half of the year, but we would expect modest improvement in the second half. And as Terrence mentioned, the benefit of our gross margin improvement plan won't materially hit our P&L until 2024. In the meantime, we are taking price in certain products and geographies to combat inflation and improve gross margin. Despite market headwinds, most of which remain out of our control, we're very excited about and remain committed to the long-term growth opportunities for the business, and we are committed to pursuing opportunities to maximize value for our shareholders. Now I will turn it back to the operator.

So I guess, I'll just start with, it's good to hear your outlook for sales being up a little bit modestly in 2023, was that low to mid-single digit growth in local currency or on a reported basis for the year?

Do you want to comment on that, Shane?

That would be in local currency.

Okay, got you. So as I think you said, the FX impact, it's kind of still there pretty negatively in the first quarter, and then it might, it sort of would get less negative or better as the year progressed. Is that the way to think about that?

That's correct. Yeah.

Okay. And then, again, I don't want to get you into making detailed projections, but when you get past the hard comparison and the less negative FX, do you think second quarter revenue can actually be up on a reported basis, or is that a little unclear at this point?

I would expect that it would be up. If you recall, most of the big hits that we took last year began in Q2. So we'll have the comp will get easier in Q2 and which will allow us to have a positive comp in Q2.

Yeah, I think we've built some of the strategies too to build momentum throughout the year, just in general.

Okay. Well that's good to hear. So again, I'm just wondering, so for your outlook, I guess you really didn't give profit or EBITDA or anything, is there something that holds you back on that giving guidance through the year on that front given that you will have sales growth for the year?

No, I think we're just, again, at this point, it's still early in the year. I think we feel good about the momentum that we have in the business. I think we have our expense base under control. We've got costs under control, but we got to want to get the top line moving and kind of see where the business is going from there and then we'll take it from there.

Okay. Sounds good. And then on inventory, I didn't glance at your balance sheet yet, but what was the inventory at the end of the year? Was it actually down sequentially?

No, it was flat sequentially to Q3.

So do you expect to have like kind of more reduction in inventory in 2023?

Absolutely. We will be working that down. Obviously, we'll have some growth that will add to some of that, but we will more than offset that growth with just right-sizing the amount of inventory that we have because we have more than we likely should have had at the end of the year.

Okay. And regarding your businesses, it's encouraging to see some signs of recovery in China. Could you provide more details about the pace of recovery and your observations there?

Yeah, as I mentioned, we're starting to see some momentum come back into the business. There's still a fair amount of uncertainty on the ground there. Consumer behavior has not simply returned to where it was prior to the zero COVID policy. As I mentioned we're hopeful that the trend line continues, but I'm going to say it's still a bit early to tell, but again, I think we feel good that we're getting positive momentum there.

Okay. And then can you talk a little bit more about Eastern Europe? Just what's going on there in terms of like, is the sales being booked from Russia and Ukraine actually zero at this point, or is there still a little bit, and then what are those new markets you referred to?

Yeah, so what we're seeing is we're able to get inventory reliably into the markets. We're able to get it into the hands of the people where we want it to go. And then we're able to get kind of repatriate the dollars once the inventory's on the ground there and it's sold in. So when I talk about us getting some stability, we really are seeing that type of stability where the business is moving forward, people are selling. And that would include both in Russia and in Ukraine albeit obviously Ukraine is at a depressed level. The performance that we're seeing in Turkey and the Baltic states, at this point in time is providing, again, some partial fill for the gap that we would have seen from Ukraine. So I think we feel really good about that. I think the team on the ground has done an outstanding job rewiring everything from how we get the product on the ground to how we deliver it to people to how we get payments. So it's been a lot of work. So I think we've reached this level of stability, and with all things kind of staying equal and all things holding steady, we feel pretty good about that. And then we've got the dollars coming in from Turkey and the Baltic states. Still new markets for us, but it's enough that it's actually, I'd say meaningful relative to what we were losing in Ukraine. Hope that's helpful.

Yes. Thank you. And then I guess just finally, I'd like to ask about North America because I guess you're still having some declines there, and I just kind of wonder about maybe the consumer pressures still facing some inflationary pressures and things like that, and yet you're kind of talking about taking price. Maybe you could just give us a little more color about how you're managing that business there in North America?

Yeah, that's an important one, especially when it comes to taking some price there and what we're specifically looking at is, on some of our specialty products, especially the botanicals where we really own some of these therapeutic areas, there is an opportunity for us to take price on some of those products. So we're going to do that. We'll be looking at all of our products and all of the pricing again, just to sharpen our pencil and make certain that we're hitting relevant price points. Some of the prices just landed on them and I think there's a better price point that people would be willing to pay. They wouldn't even notice the change, but it would make a difference to us. We are still experiencing and dealing with an inflationary market where consumers are making different choices than they were versus the marketplace in 2021. So, that does have some implications in terms of what we can do in our marketing and promotion strategies. But we do believe there's an opportunity for us to take price. We're still able to drive customer growth. We are seeing good customer growth there. Again, what's happening is as we're bringing in new customers, we're just seeing that the average orders are different than they were just 12 months ago. So we're going to keep hammering away at this. We do have other initiatives in the mix as I had mentioned, across our digital platform. And then as well looking towards our nutritional health practitioners to try and expand the number of people that we're bringing in there. That's an important initiative for us in 2023 and going forward. There are several hundred thousand health practitioners out in the marketplace that we're not tapping into right now, that would be ideal distributors for our product. We're going to be much more aggressive at trying to capture them in 2023 and beyond.

And if I could just add on a little bit there, on the price increases in North America especially, we've been very thoughtful, very careful about the way we're doing that, and frankly, are really measuring our elasticity of demand when we're doing it. So we can learn from that as well.

Okay. Okay. I'll leave it there if anybody else has questions. Thank you very much.

Okay, thank you. Hey, I'd like to thank everybody for listening to today's call, and we look forward to speaking with you when we report our first quarter, 2023 results in May of 2023. Thanks again for joining us, and take care.

Ladies and gentlemen, that concludes today's teleconference. You may disconnect your lines at this time. Thank you for your participation.